Header Logo

Connection

Assiamira Ferrara to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Assiamira Ferrara has written about Hypoglycemic Agents.
Assiamira Ferrara
Connection Strength
2.428
Hypoglycemic Agents
  1. Pioglitazone Use and Risk of Bladder Cancer--Reply. JAMA. 2015 Dec 15; 314(23):2568-9.
    View in: PubMed
    Score: 0.431
  2. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
    View in: PubMed
    Score: 0.420
  3. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
    View in: PubMed
    Score: 0.385
  4. Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
    View in: PubMed
    Score: 0.311
  5. Risk of Type 2 Diabetes Mellitus following Gestational Diabetes Pregnancy in Women with Polycystic Ovary Syndrome. J Diabetes Res. 2017; 2017:5250162.
    View in: PubMed
    Score: 0.124
  6. Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9.
    View in: PubMed
    Score: 0.102
  7. A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study. BMC Pregnancy Childbirth. 2014 Jan 15; 14:21.
    View in: PubMed
    Score: 0.094
  8. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
    View in: PubMed
    Score: 0.093
  9. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care. 2011 Apr; 34(4):916-22.
    View in: PubMed
    Score: 0.078
  10. Strategies for diabetes prevention before and after pregnancy in women with GDM. Curr Diabetes Rev. 2011 Mar; 7(2):75-83.
    View in: PubMed
    Score: 0.077
  11. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
    View in: PubMed
    Score: 0.065
  12. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
    View in: PubMed
    Score: 0.061
  13. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005 Jul; 193(1):118-24.
    View in: PubMed
    Score: 0.052
  14. Development and validation of prediction models for gestational diabetes treatment modality using supervised machine learning: a population-based cohort study. BMC Med. 2022 09 15; 20(1):307.
    View in: PubMed
    Score: 0.043
  15. Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes. JAMA Netw Open. 2022 Mar 01; 5(3):e225026.
    View in: PubMed
    Score: 0.041
  16. Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer. 2011 Apr 01; 117(7):1552-6.
    View in: PubMed
    Score: 0.019
  17. Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab. 2010 Oct; 95(10):4560-5.
    View in: PubMed
    Score: 0.019
  18. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care. 2004 Feb; 42(2):110-5.
    View in: PubMed
    Score: 0.012

© 2025 Kaiser Permanente